Dr. Cannon is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
8081 Innovation Park Dr
Fairfax, VA 22031Phone+1 571-472-4724Fax+1 571-472-0241
Education & Training
- NYU Grossman School of MedicineFellowship, Hematology and Medical Oncology, 2008 - 2011
- George Washington UniversityResidency, Internal Medicine, 2005 - 2008
- Rutgers Robert Wood Johnson Medical SchoolClass of 2005
Certifications & Licensure
- VA State Medical License 2005 - 2026
- NY State Medical License 2008 - 2012
- DC State Medical License 2005 - 2008
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- Onvansertib in Combination With Chemotherapy and Bevacizumab in Second-Line Treatment of-Mutant Metastatic Colorectal Cancer: A Single-Arm, Phase II Trial.Daniel H Ahn, Maya Ridinger, Timothy L Cannon, Lawrence Mendelsohn, Jason S Starr
Journal of Clinical Oncology. 2024-10-30 - Palbociclib in Patients With Head and Neck Cancer and Other Tumors WithAlterations: Results From the Targeted Agent and Profiling Utilization Registry Study.Francis P Worden, Evan Pisick, Michael Rothe, Pam K Mangat, Elizabeth Garrett-Mayer
JCO Precision Oncology. 2024-10-01 - Pertuzumab Plus Trastuzumab in Patients With Biliary Tract Cancer WithAlterations: Results From the Targeted Agent and Profiling Utilization Registry Study.Timothy L Cannon, Michael Rothe, Pam K Mangat, Elizabeth Garrett-Mayer, Vi K Chiu
Journal of Clinical Oncology. 2024-09-20
Press Mentions
- DC-Area Cancer Doctor Hopes FDA Action Will Save More Lives of People with Colon CancerJuly 31st, 2024
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: